SequelSEC

Verastem, Inc. VSTM

Pharmaceutical Preparations · CIK 0001526119 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$40.08M
Fiscal year ended 2026-06-30
Operating income
-$32.71M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Verastem, Inc. (VSTM) reported revenue of $40.08M and net income of -$34.67M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Verastem, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Verastem, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-312024-09-302024-06-302022-12-312022-09-30
Revenue$40.08M$18.67M$17.54M$11.24M$2.14M$0$0Unavailable$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$32.71M-$44.90M-$41.48M-$40.72M-$43.76M-$31.59M-$37.03MUnavailable-$16.85M-$17.71M
Net income-$34.67M-$36.59M-$32.92M-$98.52M-$25.93M-$64.55M-$23.97MUnavailable-$16.81M-$18.09M
Research & development$41.34M$38.22M$31.67M$28.99M$24.79M$20.81M$24.75MUnavailable$10.74M$11.29M
Weighted-average diluted sharesshares 100.12Mshares 99.15MUnavailableshares 73.16Mshares 74.04MUnavailableshares 40.26MUnavailableUnavailableshares 197.15M
Pretax income-$33.86MUnavailableUnavailableUnavailable-$25.93MUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expense$816.00K$0Unavailable$0Unavailable$185.00K$0Unavailable$0$0
Diluted EPS$-0.35$-0.46Unavailable$-1.35$-0.62Unavailable$-0.60UnavailableUnavailable$-0.09
Selling, general & administrative$27.41M$22.30M$24.44M$21.01M$20.67M$10.78M$12.28MUnavailable$6.11M$6.42M
General & administrative$8.54MUnavailableUnavailableUnavailable$7.48MUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Verastem, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-312024-09-302024-06-302022-12-312022-09-30
Cash & equivalents$136.35M$165.55M$204.99M$137.71M$164.32M$88.82M$113.18MUnavailable$74.93M$78.17M
Total assets$206.51M$227.81M$246.44M$176.85M$196.26M$101.54M$126.38MUnavailable$95.05M$111.10M
Current assets$176.16M$202.90M$223.41M$154.06M$174.27M$94.96M$120.66MUnavailable$92.87M$108.76M
Total liabilities$156.52M$146.03M$189.24M$192.38M$160.21M$130.43M$94.16MUnavailable$47.66M$48.22M
Current liabilities$78.13M$66.84M$72.27M$59.71M$50.36M$30.97M$37.37MUnavailable$21.66M$21.87M
Total equity incl. NCI$49.99M$81.78M$57.20M-$15.53M$36.06M-$28.89M$11.06MUnavailable$47.39M$62.87M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$2.40M$2.29M$1.83M$1.79M$1.17MUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$28.87M$10.16M$8.81M$6.72M$2.08MUnavailableUnavailableUnavailable$31.00K$74.00K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailable$40.72M$40.52MUnavailable$24.53M$24.40M
Accounts payable$18.00M$9.60M$12.45M$9.89M$8.05M$4.03M$4.44MUnavailable$4.90M$5.36M

Cash flow

Verastem, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-312024-09-302024-06-302022-12-312022-09-30
Operating cash flow-$43.91M-$52.12M-$29.95M-$36.22MUnavailable-$25.10M-$23.80MUnavailable-$16.62M-$15.08M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailable$0$0UnavailableUnavailableUnavailable
Investing cash flow$16.25M-$16.02M-$1.34MUnavailableUnavailable$0$0Unavailable$13.02M$4.65M
Financing cash flow-$1.54M$28.69M$98.58M$17.88MUnavailable$742.00K$53.60MUnavailable$0$25.62M
Net change in cash-$29.20M-$39.44M$67.28M-$26.62MUnavailable-$24.36M$29.80MUnavailable-$3.59M$15.19M
Stock-based compensation$3.43M$2.05M$2.02M$2.18MUnavailable$2.02M$1.94MUnavailable$1.29M$1.36M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Verastem, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-312024-09-302024-06-302022-12-312022-09-30
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailable-$25.10M-$23.80MUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-81.6%-240.5%-236.5%-362.2%-2047.9%UnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue8.6%11.0%11.5%19.4%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio2.25x3.04x3.09x2.58x3.46x3.07x3.23xUnavailable4.29x4.97x
Revenue YoY growth1775.4%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable-100.0%-100.0%
Net margin-86.5%Unavailable-187.7%-876.3%-1213.6%UnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenue103.1%204.7%180.6%257.9%1159.9%UnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VSTM in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-04View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationinconsistent2024-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationreview2024-09-30

Difference 21159000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.